Is NRPR or JNJ a better dividend investment in 2026?

NRPR currently yields 10000.00% with a 5% 5-year dividend growth rate. JNJ yields 2.14% with 5.8% growth. The better choice depends on your goal: NRPR offers higher current income.

What is the dividend yield difference between NRPR and JNJ?

NRPR has a forward dividend yield of 10000.00% ($2.00/share annually). JNJ yields 2.14% ($5.20/share annually). The yield gap is 9997.86 percentage points.

Home › Compare › NRPR vs JNJ

NRPR vs JNJ: Dividend Comparison 2026

NRPR yields 10000.00% · JNJ yields 2.14%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 NRPR wins by $55137509079256512.00M in total portfolio value

INVESTMENT

TIME HORIZON10 years

NRPR

● Live price

10000.00%

Share price

$0.02

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$55137509079256512.00M

Annual income

$54,073,795,673,722,890,000,000.00

Full NRPR calculator →

JNJ

Johnson & Johnson

● Live price

2.14%

Share price

$242.49

Annual div

$5.20

5Y div CAGR

28%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.5K

Annual income

$4,749.88

Full JNJ calculator →

Portfolio growth — NRPR vs JNJ

📍 NRPR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	NRPR	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, NRPR + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

NRPR pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NRPR

Annual income on $10K today (after 15% tax)

$850,000.00/yr

After 10yr DRIP, annual income (after tax)

$45,962,726,322,664,450,000,000.00/yr

JNJ

Annual income on $10K today (after 15% tax)

$182.28/yr

After 10yr DRIP, annual income (after tax)

$4,037.40/yr

At 15% tax rate, NRPR beats the other by $45,962,726,322,664,450,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NRPR + JNJ for your $10,000?

NRPR: 50%JNJ: 50%

100% JNJ50/50100% NRPR

Portfolio after 10yr

$27568754539628256.00M

Annual income

$27,036,897,836,861,443,000,000.00/yr

Blended yield

98.07%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

NRPR

No analyst data

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

-5.7% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NRPR buys

JNJ buys

No recent congressional trades found for NRPR or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricNRPRJNJ

Forward yield	10000.00% ✓	2.14%
Annual dividend / share	$2.00	$5.20 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	28% ✓
Portfolio after 10y	$55137509079256512.00M ✓	$30.5K
Annual income after 10y	$54,073,795,673,722,890,000,000.00 ✓	$4,749.88
Total dividends collected	$55066727460582336.00M ✓	$15.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: NRPR vs JNJ ($10,000, DRIP)

Year	NRPR Portfolio	NRPR Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$1,010,700	$1,000,000.00	$10,594	$274.49	+$1.00M → NRPR
2	$95,539,393	$94,457,943.93	$11,294	$360.69	+$95.53M → NRPR
3	$8,447,007,736	$8,344,780,585.66	$12,133	$476.91	+$8447.00M → NRPR
4	$698,565,746,383	$689,527,448,105.17	$13,156	$635.42	+$698565.73M → NRPR
5	$54,040,711,670,213	$53,293,246,321,583.74	$14,432	$854.61	+$54040711.66M → NRPR
6	$3,910,851,616,519,516	$3,853,028,055,032,387.00	$16,056	$1,162.76	+$3910851616.50M → NRPR
7	$264,781,167,546,477,440	$260,596,556,316,801,570.00	$18,175	$1,604.53	+$264781167546.46M → NRPR
8	$16,772,556,223,821,672,000	$16,489,240,374,546,942,000.00	$21,009	$2,252.68	+$16772556223821.65M → NRPR
9	$994,124,678,068,810,000,000	$976,178,042,909,320,800,000.00	$24,911	$3,229.73	+$994124678068810.00M → NRPR
10	$55,137,509,079,256,515,000,000	$54,073,795,673,722,890,000,000.00	$30,458	$4,749.88	+$55137509079256512.00M → NRPR

NRPR vs JNJ: Complete Analysis 2026

NRPR — Stock

Resilient Healthcare Corp engages in the manufacture and sale of health, beauty, and food ingredients, as well as vitamins and supplements worldwide. It also develops a process that transforms edible oils into a free-flowing powder form. The company uses its oil to powder products as ingredients in finished goods, such as food, pet food, nutraceuticals or vitamin supplements, cosmetics, and organic household products. The company was formerly known as Nutri Pharmaceuticals Research, Inc. and changed its name to Resilient Healthcare Corp in November 2025. Resilient Healthcare Corp is based in Las Vegas, Nevada.

Full NRPR Calculator →

JNJ — Healthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →

📬

Get this NRPR vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NRPR vs SCHD NRPR vs JEPI NRPR vs O NRPR vs KO NRPR vs MAIN NRPR vs ABBV NRPR vs MRK NRPR vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.